MedTrace Logo

Analgesic Effects of Midazolam in Human Volunteers

NCT02629146 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-03-11

No results posted yet for this study

Summary

This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each participant will receive all three drugs (midazolam, fentanyl, placebo) on three different occasions (study visits) and the effect on different pain stimuli will be tested.

Conditions

  • Analgesic Drugs
  • Antinociceptive Agents

Interventions

DRUG

Midazolam

DRUG

Fentanyl

DRUG

Isotonic saline

Sponsors & Collaborators

  • Akron Molecules AG

    collaborator INDUSTRY

  • Wilhelminenspital Vienna

    lead OTHER

Principal Investigators

  • Burkhard Gustorff, Prof.Dr. · Wilhelminenspital Vienna

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02629146 on ClinicalTrials.gov